ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
TC BioPharm Holdings PLC

TC BioPharm Holdings PLC (TCBP)

0.727
0.017
( 2.39% )
更新日時: 01:36:15

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
0.727
買値
0.7201
売値
0.7296
出来高
1,691,200
0.7009 日の範囲 0.8201
0.00 52 週間の範囲 0.00
時価総額
前日終値
0.71
始値
0.81
最終取引時間
01:36:32
財務取引量
US$ 1,321,957
VWAP
0.781668
平均取引量 (3 か月)
-
発行済株式数
582,020
配当利回り
-
PER
-0.07
1 株当たり利益 (EPS)
-10.15
歳入
-
純利益
-5.91M

TC BioPharm Holdings PLC について

TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform.

セクター
Coml Physical, Biologcl Resh
業界
Coml Physical, Biologcl Resh
ウェブサイト
本社
Scotland, Gbr
設立
-
TC BioPharm Holdings PLC is listed in the Coml Physical, Biologcl Resh sector of the ナスダック市場 with ticker TCBP. The last closing price for TC BioPharm was US$0.71. Over the last year, TC BioPharm shares have traded in a share price range of US$ 0.00 to US$ 0.00.

TC BioPharm currently has 582,020 shares in issue. The market capitalisation of TC BioPharm is US$413,234.20 . TC BioPharm has a price to earnings ratio (PE ratio) of -0.07.

TCBP 最新ニュース

TCBP Issues 25% Stock Dividend

TCBP Issues 25% Stock Dividend PR Newswire EDINBURGH, Scotland, Dec. 30, 2024 EDINBURGH, Scotland, Dec. 30, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company...

TCBP Advances ACHIEVE Phase 2b Clinical Trial with Final Dosing of 3 Patients

TCBP Advances ACHIEVE Phase 2b Clinical Trial with Final Dosing of 3 Patients PR Newswire EDINBURGH, Scotland, Dec. 20, 2024 EDINBURGH, Scotland, Dec. 20, 2024 /PRNewswire/ -- TC BioPharm...

TCBP Announces General Meeting of Shareholders to Approve One-Time Shareholder Dividend

TCBP Announces General Meeting of Shareholders to Approve One-Time Shareholder Dividend PR Newswire EDINBURGH, Scotland, Dec. 18, 2024 EDINBURGH, Scotland, Dec. 18, 2024 /PRNewswire/ -- TC...

TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy

TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy PR Newswire EDINBURGH, Scotland, Dec. 11, 2024 EDINBURGH...

TCBP Provides Quarterly Update on the ACHIEVE (UK) Clinical Trial

TCBP Provides Quarterly Update on the ACHIEVE (UK) Clinical Trial PR Newswire EDINBURGH, Scotland, Dec. 4, 2024 Positive safety data, allowing for exploration of higher TCB008 doses4 UK-based...

TCBP Awarded Non-Dilutive Funding, ScaleReady's G-Rex® Grant

TCBP Awarded Non-Dilutive Funding, ScaleReady's G-Rex® Grant PR Newswire EDINBURGH, Scotland, Nov. 12, 2024 EDINBURGH, Scotland, Nov. 12, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC...

TCBP Provides Shareholder Update and Highlights Recent Milestone Achievements

TCBP Provides Shareholder Update and Highlights Recent Milestone Achievements PR Newswire EDINBURGH, Scotland, Oct. 30, 2024 EDINBURGH, Scotland, Oct. 30, 2024 /PRNewswire/ -- TC BioPharm...

TCBP Responds to False Social Media Claim

TCBP Responds to False Social Media Claim PR Newswire EDINBURGH, Scotland, Oct. 25, 2024 TC BioPharm remains compliant with all Nasdaq listing requirements and will continue trading on the...

TCBP Enters Research Planning Collaboration with Dr. Carlos Maluquer de Motes for Mpox Therapeutic

TCBP Enters Research Planning Collaboration with Dr. Carlos Maluquer de Motes for Mpox Therapeutic PR Newswire EDINBURGH, Scotland, Oct. 22, 2024 EDINBURGH, Scotland, Oct. 22, 2024 /PRNewswire/...

TCBP Announces Artificial Intelligence Initiative with Partner Carnegie Mellon University for Donor Screening

TCBP Announces Artificial Intelligence Initiative with Partner Carnegie Mellon University for Donor Screening PR Newswire EDINBURGH, Scotland, Oct. 3, 2024 TC BioPharm Limited is partnering with...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

TCBP - Frequently Asked Questions (FAQ)

What is the current TC BioPharm share price?
The current share price of TC BioPharm is US$ 0.727
How many TC BioPharm shares are in issue?
TC BioPharm has 582,020 shares in issue
What is the market cap of TC BioPharm?
The market capitalisation of TC BioPharm is USD 413.23k
What is the 1 year trading range for TC BioPharm share price?
TC BioPharm has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of TC BioPharm?
The price to earnings ratio of TC BioPharm is -0.07
What is the reporting currency for TC BioPharm?
TC BioPharm reports financial results in GBP
What is the latest annual profit for TC BioPharm?
The latest annual profit of TC BioPharm is GBP -5.91M
What is the registered address of TC BioPharm?
The registered address for TC BioPharm is MAXIM 1, 2 PARKLANDS WAY, HOLYTOWN, SCOTLAND, ML1 4WR
What is the TC BioPharm website address?
The website address for TC BioPharm is www.tcbiopharm.com
Which industry sector does TC BioPharm operate in?
TC BioPharm operates in the COML PHYSICAL, BIOLOGCL RESH sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
NXUNXU Inc
US$ 1.22
(401.23%)
328.87M
WATTEnergous Corporation
US$ 1.605
(290.32%)
155.23M
INTZIntrusion Inc
US$ 5.3797
(149.06%)
104.75M
CYNCYNGN Inc
US$ 1.3101
(108.65%)
50.98M
VINCVincerx Inc
US$ 0.3643
(87.78%)
278.37M
ABPAbpro Holdings Inc
US$ 2.21
(-50.78%)
1.01M
TRAWTraws Pharma Inc
US$ 8.01
(-40.31%)
781.07k
LITMSnow Lake Resources Ltd
US$ 1.1617
(-27.39%)
40.12M
BITSGlobal X Blockchain and Bitcoin Stratagy ETF
US$ 66.40
(-24.94%)
7.25k
LICNLichen China Limited
US$ 0.1801
(-22.40%)
26.44M
NXUNXU Inc
US$ 1.22
(401.23%)
332.24M
VINCVincerx Inc
US$ 0.3643
(87.78%)
278.7M
XTIAXTI Aerospace Inc
US$ 0.04
(1.27%)
156.17M
WATTEnergous Corporation
US$ 1.605
(290.32%)
155.97M
INTZIntrusion Inc
US$ 5.3797
(149.06%)
106.24M

TCBP Discussion

投稿を表示